Idecabtagene vicleucel (Ide-cel) in patients (Pts) with newly diagnosed multiple myeloma (NDMM) with an inadequate response to front-line autologous stem cell transplantation (ASCT): KarMMa-2 cohort 2c extended follow-up Meeting Abstract
| Authors: | Paul, B.; Dhodapkar, M. V.; Alsina, M.; Berdeja, J. G.; Richard, S.; Vij, R.; Leleu, X.; Egan, D. N.; Bergsagel, P. L.; Reshef, R.; Usmani, S. Z.; Truppel-Hartmann, A.; Basudhar, D.; Thompson, E. G.; Wu, F.; Eliason, L.; Park, S.; Tran, S.; Chaudhry, M.; Siegel, D. S.; Patel, K. K. |
| Abstract Title: | Idecabtagene vicleucel (Ide-cel) in patients (Pts) with newly diagnosed multiple myeloma (NDMM) with an inadequate response to front-line autologous stem cell transplantation (ASCT): KarMMa-2 cohort 2c extended follow-up |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 3388 |
| End Page: | 3390 |
| Language: | English |
| ACCESSION: | WOS:001412633000003 |
| DOI: | 10.1182/blood-2024-200829 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
